Skip Navigation LinksHome > September 2012 - Volume 18 - Issue 6 > Interleukin 1β Blockade Improves Signs and Symptoms of Chron...
JCR: Journal of Clinical Rheumatology:
doi: 10.1097/RHU.0b013e31826149a2
Case Reports

Interleukin 1β Blockade Improves Signs and Symptoms of Chronic Calcium Pyrophosphate Crystal Arthritis Resistant to Treatment

Diamantopoulos, Andreas P. MD*†; Brodin, Christer MD*; Hetland, Helene MD*; Haugeberg, Glenn MD*†

Collapse Box


Abstract: A 54-year-old woman with recurrent episodes of bilateral knee arthritis was admitted several times to the Department of Rheumatology. She was diagnosed to have chronic calcium pyrophosphate crystal arthritis. Interleukin 1β (IL-1β) plays a central role in the pathogenesis of inflammation induced by calcium pyrophosphate crystals, and IL-1β blockade may be an effective treatment in patients with severe chronic calcium pyrophosphate crystal arthritis. Because of the short effect of treatment with corticosteroids and the frequent attacks of arthritis, the patient was treated with the IL-1 receptor antagonist anakinra. She responded well after 1 week with normalization of inflammation. Eight months after the initiation of treatment, the patient has had no relapses, although we were unable to withdraw the anakinra.

© 2012 Lippincott Williams & Wilkins, Inc.

Follow Us!


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.